GlassScriptPhysician profile
Sergey Ayzenberg
NPI 1306031125
$156,935.78
in general payments reported to CMS, 2019-2025
36 companies · $41K in 2025
The $41K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $8,078 · 2021: $14K · 2022: $18K · 2023: $19K · 2024: $29K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Food and Beverage: $20K · Consulting Fee: $9,900 · Travel and Lodging: $7,729 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44,218.75 |
| Food and Beverage | $19,640.61 |
| Consulting Fee | $9,900.00 |
| Travel and Lodging | $7,728.78 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $95,345.71 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $21,406.97 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $20,204.20 | 2021-2025 | Symplicity G3, Onyx Frontier, Resolute Onyx |
| Cook Medical LLC | $2,644.32 | 2019-2025 | Zilver Ptx, Zenith, Advance |
| Boston Scientific Corporation | $2,117.51 | 2020-2025 | Avvigo Guidance System, Farapulse, Synergy |
| Cook Incorporated | $1,886.26 | 2019-2023 | Zilver Vena |
| Abiomed | $1,717.20 | 2019-2025 | Impella |
| Cardiovascular Systems INC. | $1,586.98 | 2019-2022 | |
| Asahi Intecc USA, INC. | $1,489.13 | 2023-2025 | Asahi Peripheral Vascular Wires, Asahi Ptca Guide Wire, Peripheral Vascular |
| Philips North America LLC | $1,449.50 | 2024-2025 | Coronary Other, Coronary Undivided, (Br0) Coronary Atherectomy |
| Penumbra, INC. | $1,079.18 | 2019-2025 | Indigo System |
| Pfizer INC. | $927.11 | 2019-2025 | |
| Abbott Laboratories | $671.59 | 2019-2025 | Diamondback Peripheral, Navitor, Supera |
| Novartis Pharmaceuticals Corporation | $637.09 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $477.83 | 2021-2025 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergey Ayzenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.